Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

ICCC

ImmuCell (ICCC)

ImmuCell Corporation
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:ICCC
FechaHoraFuenteTítuloSímboloCompañía
04/06/202415:05GlobeNewswire Inc.ImmuCell to Hold Virtual-Only Annual Meeting of StockholdersNASDAQ:ICCCImmuCell Corporation
22/05/202415:50Edgar (US Regulatory)Form SCHEDULE 13D - General statement of acquisition of beneficial ownershipNASDAQ:ICCCImmuCell Corporation
14/05/202415:06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ICCCImmuCell Corporation
14/05/202415:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ICCCImmuCell Corporation
14/05/202415:05GlobeNewswire Inc.ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2024NASDAQ:ICCCImmuCell Corporation
08/05/202412:00GlobeNewswire Inc.ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2024NASDAQ:ICCCImmuCell Corporation
09/04/202415:05GlobeNewswire Inc.ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 2024NASDAQ:ICCCImmuCell Corporation
27/02/202415:05GlobeNewswire Inc.ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2023NASDAQ:ICCCImmuCell Corporation
16/02/202408:30GlobeNewswire Inc.ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2023NASDAQ:ICCCImmuCell Corporation
08/01/202415:05GlobeNewswire Inc.ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 2023NASDAQ:ICCCImmuCell Corporation
13/11/202315:05GlobeNewswire Inc.ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2023NASDAQ:ICCCImmuCell Corporation
07/11/202311:15GlobeNewswire Inc.ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2023NASDAQ:ICCCImmuCell Corporation
05/10/202315:05GlobeNewswire Inc.ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 2023NASDAQ:ICCCImmuCell Corporation
06/09/202311:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ICCCImmuCell Corporation
29/08/202307:00GlobeNewswire Inc.ImmuCell Announces Submission of CMC Technical Section to the FDANASDAQ:ICCCImmuCell Corporation
10/08/202315:05GlobeNewswire Inc.ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2023NASDAQ:ICCCImmuCell Corporation
07/08/202311:00GlobeNewswire Inc.ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2023NASDAQ:ICCCImmuCell Corporation
13/07/202313:28Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ICCCImmuCell Corporation
11/07/202315:05GlobeNewswire Inc.ImmuCell Announces Preliminary, Unaudited Sales Results for Q2 2023NASDAQ:ICCCImmuCell Corporation
29/06/202312:03Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ICCCImmuCell Corporation
28/06/202315:05GlobeNewswire Inc.ImmuCell Announces Change in Timing of Anticipated FDA SubmissionNASDAQ:ICCCImmuCell Corporation
21/06/202315:05GlobeNewswire Inc.ImmuCell Appoints Bryan K. Gathagan to Board of DirectorsNASDAQ:ICCCImmuCell Corporation
15/06/202315:05GlobeNewswire Inc.ImmuCell Announces Approval of Principal Terms of a $3 Million Debt FacilityNASDAQ:ICCCImmuCell Corporation
11/05/202315:07Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ICCCImmuCell Corporation
11/05/202315:05GlobeNewswire Inc.ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2023NASDAQ:ICCCImmuCell Corporation
04/05/202305:30GlobeNewswire Inc.ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2023NASDAQ:ICCCImmuCell Corporation
28/04/202309:18Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:ICCCImmuCell Corporation
28/04/202309:14Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ICCCImmuCell Corporation
18/04/202316:11Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:ICCCImmuCell Corporation
05/04/202315:05GlobeNewswire Inc.ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 2023NASDAQ:ICCCImmuCell Corporation
 Showing the most relevant articles for your search:NASDAQ:ICCC